Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
Chemical Communications (Cambridge, England)|May 22, 2020
NO release regulated by doxorubicin as the green light-harvesting antennaAurore Fraix, Cristina Parisi, Mariacristina Failla, et al.Antioxidants (Basel, Switzerland)|January 21, 2022
Multitarget Antioxidant NO-Donor Organic Nitrates: A Novel Approach to Overcome Nitrates Tolerance, an Ex Vivo StudyElisabetta Marini, Marta Giorgis, Marta Leporati, et al.Journal of Microencapsulation|July 1, 2016
Solid lipid nanoparticles carrying lipophilic derivatives of doxorubicin: preparation, characterization, and in vitro cytotoxicity studiesElena Peira, Daniela Chirio, Luigi Battaglia, et al.Pharmaceutics|January 25, 2025
Synthesis of Arginase Inhibitors: An OverviewMaria Cristina Molaro, Chiara Battisegola, Marica Erminia Schiano, et al.Journal of Medicinal Chemistry|March 6, 2007
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator propertiesKonstantin Chegaev, Loretta Lazzarato, Paolo Tosco, et al.Journal of Medicinal Chemistry|December 31, 2008
Edaravone derivatives containing NO-donor functionsKonstantin Chegaev, Clara Cena, Marta Giorgis, et al.European Journal of Medicinal Chemistry|January 1, 2018
Structural and biological characterization of new hybrid drugs joining an HDAC inhibitor to different NO-donorsSandra Atlante, Konstantin Chegaev, Chiara Cencioni, et al.Journal of Medicinal Chemistry|June 24, 2016
Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4'-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoproteinStefano Guglielmo, Loretta Lazzarato, Marialessandra Contino, et al.Chemmedchem|December 22, 2006
Amphiphilic NO-donor antioxidantsKonstantin Chegaev, Loretta Lazzarato, Barbara Rolando, et al.Molecular Pharmaceutics|July 25, 2014
Liposomal nitrooxy-doxorubicin: one step over caelyx in drug-resistant human cancer cellsIsabella Pedrini, Elena Gazzano, Konstantin Chegaev, et al.Pageof 6